SPC233

Búrósúmab

  • Status:
    Veitt
  • Application date:
    14.8.2018
  • Application published:
    15.9.2018
  • Grant published:
    15.3.2021
  • Max expiry date:
    13.2.2033
  • Medicine name:
    Crysvita
  • Medicine for children:
    No

Timeline

Today
14.8.2018Application
15.9.2018Publication
15.3.2021Registration
13.2.2033Expires

Marketing license

  • IS authorization number:
    EU/1/17/1262/001-003
  • Date:
    26.2.2018
  • Foreign authorization number:
    EU/1/17/1262
  • Date:
    19.2.2018

Owner

  • Name:
    Kyowa Kirin Co., Ltd.
  • Address:
    1-9-2, Otemachi, Chiyoda-ku, Tokyo 100-0004 JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents